The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dobrynina L.A.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Gadzhieva Z.Sh.

Research Center of Neurology, Moscow, Russia

Akhmetzyanov B.M.

Research Center of Neurology, Moscow, Russia

Krotenkova M.V.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

Kalashnikova L.A.

Nauchnyĭ tsentr nevrologii RAMN, Moskva

The role of arterial, venous blood and cerebrospinal fluid flow disturbances in forming cognitive impairment types in age-related cerebral microangiophathy

Authors:

Dobrynina L.A., Gadzhieva Z.Sh., Akhmetzyanov B.M., Krotenkova M.V., Kalashnikova L.A.

More about the authors

Read: 3535 times


To cite this article:

Dobrynina LA, Gadzhieva ZSh, Akhmetzyanov BM, Krotenkova MV, Kalashnikova LA. The role of arterial, venous blood and cerebrospinal fluid flow disturbances in forming cognitive impairment types in age-related cerebral microangiophathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2019;119(12‑2):81‑88. (In Russ.)
https://doi.org/10.17116/jnevro201911912281

Recommended articles:
Quantitative analysis of cere­brospinal fluid flow in multiple scle­rosis patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7-2):45-50
Novel prospects for early diagnosis of cognitive impairment using Eye-tracking technology. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):13-20
Features of care of patients with cardiovascular diseases and cognitive diso­rders. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(6):99-104
Cere­bral microangiopathy. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(7):15-24
Cardiogenic deme­ntia. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):43-49
Diagnosis of Alzheimer’s disease using biological markers in corticobasal syndrome. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(8):133-139

References:

  1. Gorelick PB, Scuter A, Black SE, DeCarli C, Greenberg SM, Iadecola C, Petersen R. C. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2011;42:2672-2713. https://doi.org/10.1161/str.0b013e3182299496
  2. Deramacourt V, Slade JY, Oakley AE, Perry RH, Ince PG, Maurage CA, Kalaria RN. Staging and natural history of cerebrovascular pathology in dementia. Neurology. 2012;78:1043-1050. https://doi.org/10.1212/01.wnl.0000416262.36658.49
  3. Wardlaw JM, Smith EE, Biessels GJ, Cordonnier C, Fazekas F, Frayne R, Black SE. Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration. Lancet Neurol. 2013;12:822-838. https://doi.org/10.1016/s1474-4422(13)70124-8
  4. Grinberg LT, Nitrini R, Suemoto CK, de Lucena Ferretti-Rebustini RE, Leite RE, Farfel JM, Oliveira KC. Prevalence of dementia subtypes in a developing country: a clinicopathological study. Clinics. 2013;68(8):1140-1145. https://doi.org/10.6061/clinics/2013(08)13
  5. Attems J, Jellinger KA. The overlap between vascular disease and Alzheimer’s disease-lessons from pathology. BMC Medicine. 2004;12(1):206. https://doi.org/10.1186/s12916-014-0206-2
  6. Chui HC, Ramirez-Gomez L. Clinical and imaging features of mixed Alzheimer and vascular pathologies. Alzheimers Res Ther. 2015;7(1):21. https://doi.org/10.1186/s13195-015-0104-7
  7. McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Kalaria RN. Post-mortem assessment in vascular dementia: advances and aspirations. BMC Medicine. 2016;14(1):129. https://doi.org/10.1186/s12916-016-0676-5
  8. Livingston G, Sommerlad A, Orgeta V, Costafreda SG, Huntley J, Ames D. Dementia prevention, intervention, and care. The Lancet. 2017;390(10113):2673-2734. https://doi.org/10.1016/s0140-6736(17)31363-6
  9. Smith EE, Beaudin AE. New insights into cerebral small vessel disease and vascular cognitive impairment from MRI. Curr Opin Neurol. 2018;31(1):36-43. https://doi.org/10.1097/wco.0000000000000513
  10. Custodio N, Montesinos R, Lira D, Herrera-Pérez E, Bardales Y, Valeriano-Lorenzo L. Mixed dementia: A review of the evidence. Dementia & Neuropsychologia. 2017;11(4):364-370. https://doi.org/10.1590/1980-57642016dn11-040005
  11. Iadecola C, Duering M, Hachinski V, Joutel A, Pendlebury ST, Schneider JA. Vascular Cognitive Impairment and Dementia: JACC Scientific Expert Panel. Journal of the American College of Cardiology. 2019;73(25):3326-3344. https://doi.org/10.1016/j.jacc.2019.04.034
  12. Fisher CM. The arterial lesions underlying lacunes. Acta Neuropathological. 1969;12(1):1-15.
  13. Gulevskaya TS, Morgunov VA. Patologicheskaya anatomiya narushenii mozgovogo krovoobrashcheniya pri ateroskleroze i arterial’noi gipertonii. M.: Meditsina; 2009. (In Russ)
  14. Kalashnikova LA, Kulov BB. Faktory riska subkortikal’noi arterioskleroticheskoi entsefalopatii. Zhurnal Nevrologii i Psikhiatrii im. C.C. Korsakova. 2002;102(7):3-8. (In Russ.)
  15. Damulin IV, Bryzhakhina VG, Shishkova EV, Yakhno NN. Narusheniya khod’by i ravnovesiya pri distsirkulyatornoi entsefalopatii. Soobshchenie 2. Kliniko-neiropsikhologicheskie i MRT-sopostavleniya. Nevrologicheskii zhurnal. 2004;9(4):13-13. (In Russ.)
  16. Pantoni L. Cerebral small vessel disease: from pathogenesis and clinical characteristics to therapeutic challenges. The Lancet Neurology. 2010;9(7):689-701. https://doi.org/10.1016/S1474-4422(10)70104-6
  17. Shi Y, Thrippleton MJ, Makin SD, Marshall I, Geerlings MI, de Craen AJ, Wardlaw JM. Cerebral blood flow in small vessel disease: A systematic review and meta-analysis. J Cereb Blood Flow Metab. 2016;36:1653-1667. https://doi.org/10.1177/0271678x16662891
  18. Santisteban MM, Iadecola C. Hypertension, dietary salt and cognitive impairment. Journal of Cerebral Blood Flow & Metabolism. 2018;38(12):2112-2128. https://doi.org/10.1177/0271678X18803374
  19. Sachdev P, Kalaria R, O’Brien J, Skoog I, Alladi S, Black SE. Diagnostic criteria for vascular cognitive disorders: a VASCOG statement. Alzheimer Disease and Associated Disorders. 2014;28(3):206-218. https://doi.org/10.1097/wad.0000000000000034
  20. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270-279. https://doi.org/10.1176/appi.focus.11.1.96
  21. Scott TM, Bhadelia RA, Qiao Qiu W, Folstein MF, Rosenberg IH. Small Vessel Cerebrovascular Pathology Identified by Magnetic Resonance Imaging Is Prevalent in Alzheimer’s Disease and Mild Cognitive Impairment: A Potential Target for Intervention. Journal of Alzheimer’s Disease. 2018;65(1):293-302. https://doi.org/10.3233/jad-180366
  22. Yakhno NN, Zakharov VV, Lokshina AB. Sindrom umerennykh kognitivnykh narushenii pri distsirkulyatornoi entsefalopatii. Zhurnal Nevrolologii i Psikhiatrii im. S.S. Korsakova. 2005;105(2):13-17. (In Russ.)
  23. Reed BR, Mungas DM, Kramer JH, Ellis W, Vinters HV, Zarow C. Profiles of neuropsychological impairment in autopsy-defined Alzheimer’s disease and cerebrovascular disease. Brain. 2007;130(Pt3):731-739. https://doi.org/10.1093/brain/awl385
  24. Lawrence AJ, Patel B, Morris RG, MacKinnon AD, Rich PM, Barrick TR. Mechanisms of cognitive impairment in cerebral small vessel disease: multimodal MRI results from the St George’s cognition and neuroimaging in 140 stroke (SCANS) study. PloS One. 2013;8(4):e61014. https://doi.org/10.1371/annotation/bbde462e-c699-4c4d-9b61-050c7e6e5ce3
  25. Dobrynina LA, Gadzhieva ZSh, Kalashnikova LA, Akhmetzyanov BM, Kremneva EI, Krotenkova MV, Lagoda DYu, Zabitova MR, Poddubskaya AA, Berdalin AB. Neiropsikhologicheskii profil’ i faktory sosudistogo riska u bol’nykh s tserebral’noi mikroangiopatiei. Annaly Nevrologii. 2018;12(4):5-15. (In Russ.)
  26. Dichgans M, Wardlaw J, Smith E, Zietemann V, Seshadri S, Sachdev P. METACOHORTS for the study of vascular disease and its contribution to cognitive decline and neurodegeneration: An initiative of the Joint Programme for Neurodegenerative Disease Research. Alzheimer’s & Dementia. 2016;12(12):1235-1249. https://doi.org/10.1016/j.jalz.2016.06.004
  27. Smith EE, Biessels GJ, De Guio F, de Leeuw FE, Duchesne S, Düring M, Thrippleton MJ. Harmonizing brain magnetic resonance imaging methods for vascular contributions to neurodegeneration. Alzheimer’s & Dementia: Diagnosis, Assessment & Disease Monitoring. 2019;11:191-204. https://doi.org/10.1016/j.dadm.2019.01.002
  28. Dobrynina LA, Akhmetzyanov BM, Gadzhieva ZSh, Kremneva EI, Kalashnikova LA, Krotenkova MV. Rol’ narushenii arterial’nogo, venoznogo krovotoka i likvorotoka v razvitii kognitivnykh rasstroistv pri tserebral’noi mikroangiopatii. Annaly Klinicheskoi i Eksperimental’noi Nevrologii. 2019;13(2):19-31. (In Russ.)
  29. Bateman GA. Pulse-wave encephalopathy: a comparative study of the hydrodynamics of leukoaraiosis and normal pressure hydrocephalus. Neuroradiology. 2002;44:740-748. https://doi.org/10.1007/s00234-002-0812-0
  30. Bateman GA, Levi CR, Schofield P. The venous manifestations of pulse wave encephalopathy: windkessel dysfunction in normal aging and senile dementia. Neuroradiology. 2008;50(6):491-497. https://doi.org/10.1007/s00234-008-0374-x
  31. Nasreddine ZS, Phillips NA, Bedirian V, Charbonneau S, Whitehead V, Collin I. The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. J Am Geriatr Soc. 2005;4:695-699. https://doi.org/10.1111/j.1532-5415.2005.53221.x
  32. Arlington VA. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. Fifth Edition. Washington: American Psychiatric Association; 2013. https://doi.org/10.1176/appi.books.9780890425596
  33. Rivera-Rivera LA, Schubert T, Turski P, Johnson KM, Berman SE, Rowley HA. Changes in intracranial venous blood flow and pulsatility in Alzheimer’s disease: A 4D flow MRI study. Journal of Cerebral Blood Flow & Metabolism. 2017;37(6):2149-2158. https://doi.org/10.1177/0271678x16661340
  34. Baledent O, Henry-Feugeas MC, Idy-Peretti I. Cerebrospinal fluid dynamics and relation with blood flow: a magnetic resonance study with semi-automated cerebrospinal fluid segmentation. Invest Radiol. 2001;36:368-377. https://doi.org/10.1097/00004424-200107000-00003
  35. Stoquart-ElSankari S, Balédent O, Gondry-Jouet C, Makki M, Godefroy O, Meyer ME. Aging effects on cerebral blood and cerebrospinal fluid flows. Journal of Cerebral Blood Flow & Metabolism. 2007;27(9):1563-1572. https://doi.org/10.1038/sj.jcbfm.9600462
  36. Shim YS, Yang DW, Roe CM, Coats MA, Benzinger TL, Xiong C, Morris JC. Pathological correlates of white matter hyperintensities on magnetic resonance imaging. Dement Geriatr Cogn Disord. 2015;39(1-2):92-104. https://doi.org/10.1016/j.jalz.2011.05.2045
  37. Iliff JJ, Wang M, Liao Y, Plogg BA, Peng W, Gundersen GA, Nagelhus EA. A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci Transl Med. 2012;4:1-11. https://doi.org/10.1126/scitranslmed.3003748
  38. Iliff JJ, Wang M, Zeppenfeld DM, Venkataraman A, Plog BA, Liao Y, Nedergaard M. Cerebral arterial pulsation drives paravascular CSF-interstitial fluid exchange in the murine brain. J Neurosci. 2013;33:18190-18199. https://doi.org/10.1523/jneurosci.1592-13.2013
  39. Zlokovic BV. Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders. Nature Reviews Neuroscience. 2011;12(12):723. https://doi.org/10.1038/nrn3114

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.